Current Clinical Trials The Kimmel Cancer Center at Jefferson is a National Cancer Institute (NCI)-designated cancer center. The site lists current clinical trials as well as information for patients and families, researchers and healthcare professionals. Jefferson Cancer Network Thomas Jefferson University Hospital and Thomas Jefferson University operate the Jefferson Cancer Network (JCN), a network of hospitals in the region dedicated to the furthering of clinical research and education in the prevention, diagnosis and treatment of cancer. To find out more about current clinical trials that you may be able to participate in, ask your doctor or call 215-955-1661 during regular business hours or 1-800-JEFF-NOW after 5 p.m. Patients with breast cancer who are experiencing clinical depression may be eligible to participate in a clinical research study using an antidepressant approved by the U.S. Food and Drug Administration. This study is being conducted by Thomas Jefferson University’s Department of Psychiatry. Qualified participants will not be charged for their study-related doctor visits, tests and medications, and will receive compensation for their time and travel. 215-503-2833

When laboratory research shows that a new treatment method has promise, patients with cancer have the opportunity to receive the treatment in clinical trials or protocols. These trials are designed to answer important questions and determine whether the new approach is safe and effective.

By participating in a clinical trial, you may have the first chance to benefit from improved treatment methods and the opportunity to make an important contribution to medical science.

We are at the forefront of cancer research, with major funding from the National Cancer Institute, and we are among the top two facilities in Philadelphia receiving American Cancer Society funding.

Our research has led to new chemotherapy and radiation treatment plans for patients with certain brain tumors, lung cancers, colorectal cancer and cancer of the head-and-neck region.

Our researchers also have developed a new test that uses the presence or absence of a specific gene to identify uterine tumors as benign or malignant. It is especially important for women of childbearing age who have been told they may have cancer and may need a hysterectomy.

Plus, we are conducting trials of anti-cancer drugs, some available only through our facilities. New therapies and alternate treatment options available through clinical trials make Jefferson one of the best choices for quality cancer care.